Cristae Therapeutics is a startup based in the United Kingdom.
Based in the United Kingdom, Cristae Therapeutics is a startup.
Develops small-molecule therapeutics aimed at restoring mitochondrial function to treat neurodegenerative and rare diseases; the company cites over ten years of R&D and a proprietary library of 700+ novel compounds.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.